En Español

Free Case Evaluation

877-975-7991

CHAT LIVE NOW

Prescription Error Attorneys in Illinois

The Chicago drug injury attorneys at Salvi, Schostok & Pritchard P.C., are skilled advocates for individuals who have been harmed by the use of prescription drugs. Pharmaceutical companies have a duty to properly research the side effects of their drugs. They also must provide adequate warnings of any potential dangers from using prescribed medicine.

VERDICTS AND SETTLEMENTS

  • $3.75 Million – Wrongful death
  • $4.5 Million – Personal Injury
  • $15.2 Million Personal Injury Verdict - Patrick A. Salvi II, Patrick A. Salvi, Jeffrey J. Kroll and Aaron D. Boeder...

    $15.2 Million Personal Injury Verdict

    Patrick A. Salvi II, Patrick A. Salvi, Jeffrey J. Kroll and Aaron D. Boeder of the law firm Salvi, Schostok & Pritchard P.C. of Chicago, IL obtained a $15.2 million verdict on behalf of a man who was seriously injured when he was struck and run over by a forklift at McCormick Place convention center in Chicago, Illinois. The trial began on August 4, 2015. The verdict was approved by the Honorable Judge Lorna E. Propes in the Circuit Court of Cook County.

    On September 18, 2012, Thomas Neuhengen of Cudahy, Wisconsin, 33, was working as a spare parts manager for Hermle Machine Co. LLC, helping with the tear down of the company’s booth from the International Manufacturing Technology Show (IMTS) at McCormick Place. He was knocked down and his left foot was run over by a 58,000 pound 40/60 Versa Lift forklift. Neuhengen’s attorneys allege the forklift driver, Frederick Neirinckx, failed to keep a clear view of the path of travel, failed to maintain a proper lookout and failed to use a spotter.

    Additionally, according to the complaint, Global Experience Specialists, the company that set up the show and hired Mr. Neirinckx did not have a policy in place to make sure forklift drivers were trained and evaluated three-years prior to the 2012 IMTS. The company also failed to assign a three-person crew to the 40/60 Versa Lift. Global Experience Specialists was cited with four safety violations by the U.S. Occupational Safety and Health Administration.

    As a result of the accident, Mr. Neuhegen suffered a de-gloving injury to his left foot, requiring a number of surgeries. Mr. Neuhegen is a staff sergeant in the Wisconsin Army National Guard and prior to the incident served two tours of duty in Iraq.

    “As a result of a corporation ignoring safety rules, Tom’s life will never be the same,” said lawyer Patrick Salvi II. “The jury’s verdict demonstrates the substantial impact and ongoing challenges this incident has had on Tom. We hope this verdict serves as a reminder to companies to ensure employees receive proper training and resources.”

See More

FIND OUT IF YOU HAVE A CASE

TALK TO AN EXPERIENCED ATTORNEY

When drug makers fall short in those duties, innocent consumers can suffer serious injuries. A prime example relates to Actos, a drug prescribed to control the blood sugar levels in individuals with Type II diabetes (adult onset).

Actos has been linked to bladder cancer, as well as other potential side effects such as liver and kidney damage, heart attacks, congestive heart failure, blindness, and bone fractures.

Do you suspect you have been harmed by Actos? Contact us today at 877-975-7991 for a free, initial consultation on your potential legal rights. Salvi, Schostok & Pritchard P.C., has obtained more than $900 million in verdicts and settlements on behalf of our injury clients. Our record includes 200 cases with verdicts or settlements of $1 million or more.

Don’t delay. Time is of the essence because filing deadlines apply, and valuable evidence may be lost if you do not act quickly.

FDA Warning On Actos Side Effects

Actos is manufactured by Takeda Pharmaceuticals of Japan and marketed in the United States by Eli Lilly & Co. Since it was first approved by the Federal Drug Administration in 1999, doctors have widely prescribed Actos. According to the FDA, more than 2.3 million people filled prescriptions for Actos in 2010.

Related medications include ActoPlus Met (pioglitazone and metformin), ActoPlus Met XR (extended release) and Duetact (glimepiride and pioglitazone).

In June 2011 the FDA issued a warning about the increased risk of bladder cancer for individuals who have been taking Actos for more than one year. Signs of bladder cancer include:

  • Bloody or reddish urine;
  • An urgent need to urinate;
  • Pain during urination;
  • Pain in the back or lower abdomen.

If you have any of these symptoms, you should immediately seek medical attention.

If you or a loved one is taking or has taken Actos (pioglitazone hydrochloride) and have suffered bladder cancer or any other injurious side effects, you may have a legal claim against the maker and distributor of the drug. You might be entitled to monetary compensation for your medical expenses and pain and suffering because of Actos’ side effects.

We Are Investigating Claims

The Chicago defective drug attorneys at Salvi, Schostok & Pritchard P.C., are investigating legal claims related to the side effects of Actos, including bladder cancer. We can analyze the facts of your particular situation and advise you about what legal steps you should take next.

We have a track record of success in handling claims of individuals who have been injured because of defective drugs. Our experience as personal injury attorneys provides us with the knowledge and skills needed to effectively deal with insurance companies and drug makers. These cases can be complicated, and we have the know-how and experience to handle them.

Call us at 877-975-7991 or use our online contact form to set up a free, initial consultation to discuss your legal rights.

Blog

15

July

2015

Bellwether Trials Scheduled for Xarelto

by

A series of four bellwether trials in the federal multi-district litigation for Xarelto are set to begin in August 2016. Over the past several months, all product liability complaints involving the blood thinning medication have been consolidated before U.S. District…

Read More From Our Blog